Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Biomerica (BMRA) over the last 16 years, with Q4 2025 value amounting to -$47000.0.

  • Biomerica's Change in Accured Expenses rose 8049.79% to -$47000.0 in Q4 2025 from the same period last year, while for Nov 2025 it was -$286000.0, marking a year-over-year decrease of 53333.33%. This contributed to the annual value of -$466000.0 for FY2025, which is 28943.09% down from last year.
  • As of Q4 2025, Biomerica's Change in Accured Expenses stood at -$47000.0, which was up 8049.79% from -$63000.0 recorded in Q3 2025.
  • In the past 5 years, Biomerica's Change in Accured Expenses registered a high of $1.0 million during Q1 2022, and its lowest value of -$1.6 million during Q2 2022.
  • Moreover, its 5-year median value for Change in Accured Expenses was -$48000.0 (2024), whereas its average is -$34785.8.
  • Its Change in Accured Expenses has fluctuated over the past 5 years, first plummeted by 84726.67% in 2022, then surged by 700000.0% in 2023.
  • Quarter analysis of 5 years shows Biomerica's Change in Accured Expenses stood at $878501.0 in 2021, then plummeted by 100.11% to -$1000.0 in 2022, then skyrocketed by 7000.0% to $69000.0 in 2023, then plummeted by 449.28% to -$241000.0 in 2024, then soared by 80.5% to -$47000.0 in 2025.
  • Its Change in Accured Expenses was -$47000.0 in Q4 2025, compared to -$63000.0 in Q3 2025 and $40000.0 in Q2 2025.